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Case description
A 59-year-old asymptomatic man, with a history of previous transient
ischaemic attack and patent foramen ovale (PFO) closure with an
Amplatzer 24-mm atrial septal defect occluder device (Abbott
Vascular; Abbott Park, IL, USA), performed in another centre
15 months before, was admitted to our hospital for a routine echocar-
diographic follow-up. Transthoracic echocardiogram showed the ab-
sence of the occluder device in the interatrial septum and a huge septal
aneurysm with moderate right-to-left shunt detected after saline injec-
tion during Valsalva manoeuvre (Figure 1, Supplementary material on-
line, Videos S1 and S2). Subsequently, the patient underwent computed
tomography angiography of the thoracoabdominal aorta, which con-
firmed the migration of the device in the aortic arch (Figure 2).
Considering the high risk of complications due to percutaneous man-
agement, the patient was scheduled for a surgical retrieval of the device.
Patent foramen ovale closure device embolization is rare and typ-
ically occurs early after deployment. Common sites of migration are
Figure 1 Transthoracic echocardiogram showing the absence of the Amplatzer occluder device and the atrial septal aneurysm bulging to the right
atrium (A, four-chamber view, arrow). Colour-Doppler imaging showing a left-to-right interatrial jet with a patent foramen ovale (B).
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..cardiac chambers, pulmonary artery, aortic arch, descending and ab-
dominal aorta. Reported anatomical predisposing factors are an atrial
septal aneurysm, a thick septum secundum (>10 mm) or a long tun-
nel.1 In our case, we believe that an undersized device together with
the large atrial septal aneurysm was the possible mechanism for the
failure of the PFO repair. Larger devices are usually indicated in cases
of atrial septal aneurysm in order to cover the entire redundant sep-
tum. We can suppose the embolization occurred early, but we don’t
have any previous echocardiographic images available for compari-
son. A successfully placed PFO closure device straddles the thick
muscular septum secundum with its two disks and is subsequently
covered up and stabilized by endothelial tissue, so the long-term dis-
lodgement is uncommon.2 Given the inability of these devices to re-
tract and compress, as they would when initially implanted,3 to allow
the passage into a vascular sheath, often an open-heart surgical ap-
proach is recommended.
Supplementary material
Supplementary material is available at European Heart Journal - Case
Reports online.
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Figure 2 Computed tomography angiography showing the migrated Amplatzer occluder device at the origin of the left common carotid artery in
a bovine aortic arch (A, MIP oblique reconstruction, arrow). It was embedded into the aortic wall (B, dotted arrow), with a filling defect at the waist
level (B, asterisk). AoArch, aortic arch; AsAo, ascending thoracic aorta; BCA, brachiocephalic artery; DesAo, descending thoracic aorta; LCCA, left
common carotid artery; LSCA, left subclavian artery.
2 M.E. Mancini et al.
